Lantheus (LNTH) is down -8.7%, or -$7.08 to $74.18.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH:
- Optimistic Growth Prospects for Lantheus Amid Pricing Challenges: A Buy Recommendation
- Leerink says CMS proposal not surprising, Lantheus could still see volatility
- Lantheus investors likely disappointed with CMS proposal, says William Blair
- Lantheus: Strategic Growth and Market Leadership in Radiopharmaceuticals Justify Buy Rating
- Lantheus price target lowered to $109 from $122 at B. Riley